Effect of additive renin inhibition with aliskiren on renal blood flow in patients with Chronic Heart Failure and Renal Dysfunction (Additive Renin Inhibition with Aliskiren on renal blood flow and Neurohormonal Activation in patients with Chronic Heart Failure and Renal Dysfunction)
- 1 May 2015
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 169 (5) , 693-701.e3
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysisEuropean Heart Journal, 2013
- Systemic arterial and venous determinants of renal hemodynamics in congestive heart failureHeart Failure Reviews, 2011
- Differential associations between renal function and “modifiable” risk factors in patients with chronic heart failureClinical Research in Cardiology, 2008
- Meta-Analysis: Angiotensin-Receptor Blockers in Chronic Heart Failure and High-Risk Acute Myocardial InfarctionAnnals of Internal Medicine, 2004
- Renal Dysfunction Complicating the Treatment of HypertensionNew England Journal of Medicine, 2002
- Renal Function, Neurohormonal Activation, and Survival in Patients With Chronic Heart FailureCirculation, 2000
- Renal responses to antagonism of the renin-angiotensin systemCurrent Opinion in Nephrology and Hypertension, 1996
- Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart FailureJAMA, 1995
- Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.Circulation, 1990
- Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure.Circulation, 1986